Guatam Sethi

Sethi Guatam

  • Associate Professor, Department of Pharmacology
Administrative Appointment(s)
  • Safety Lead, Safety and Health Committee, Department of Pharmacology
Academic Qualifications
  • PhD, Banaras Hindu University, India
  • MSc, Banaras Hindu University, India
  • BSc (Honours), Banaras Hindu University, India
Research Interest(s)
  • Transcription Factors
  • Cell Signaling
  • Chemoprevention
  • Pharmaceuticals
Recent Publications
  • 1. Wang L, Syn NLX, Subhash VV, Any Y, Thuya WL, Cheow ESH, Kong L, Yu F, Peethala PC, Wong ALA et al. 2018 Mar. Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signalling. Cancer Letters. 417:152-160. doi: 10.1016/j.canlet.2017.12.030.
  • 2. Banik K, Harsha C, Bordoloi D, Lalduhsaki Sailo B, Sethi G, Leong HC, Arfuso F, Mishra S, Wang L, Kumar AP et al. 2018 Mar. Therapeutic potential of gambogic acid, a caged xanthone, to target cancer. Cancer Letters. 416:75-86. doi: 10.1016/j.canlet.2017.12.014.
  • 3. Singh SS, Vats S, Chia AYQ, Tan TZ, Deng S, Ong MS, Arfuso F, Yap CT, Goh BC, Sethi G et al. 2017 Dec. Dual role of autophagy in hallmarks of cancer. Oncogene. 1-17. doi: 10.1038/s41388-017-0046-6.
  • 4. Ko JH, Sethi G, Um J-, Shanmugam MK, Arfuso F, Kumar AP, Bishayee A, Ahn KS. 2017 Dec. The Role of Resveratrol in Cancer Therapy. International Journal of Molecular Sciences. 18(12): 2589. doi: 10.3390/ijms18122589.
  • 5. Sethi G, Shanmugam MK, Kumar AP. 2017 Dec. SREBP-1c as a molecular bridge between lipogenesis and cell cycle progression of clear cell renal carcinoma. Bioscience Reports. 37(6). doi: 10.1042/BSR20171270.